# Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma

> **NCT00821301** · PHASE1 · UNKNOWN · sponsor: **Immune Control** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Fluphenazine HCl

## Key facts

- **NCT ID:** NCT00821301
- **Lead sponsor:** Immune Control
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2010-08
- **Final completion:** 2010-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00821301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00821301, "Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00821301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*